- Home
- BBIO vs FICO Comparison
BBIO vs FICO Comparison
Compare BBIO & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FICO
- Stock Information
- Founded
- BBIO 2015
- FICO 1956
- Country
- BBIO United States
- FICO United States
- Employees
- BBIO N/A
- FICO N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FICO Business Services
- Sector
- BBIO Health Care
- FICO Consumer Discretionary
- Exchange
- BBIO Nasdaq
- FICO Nasdaq
- Market Cap
- BBIO 8.0B
- FICO 44.5B
- IPO Year
- BBIO 2019
- FICO 1987
- Fundamental
- Price
- BBIO $46.97
- FICO $1,505.39
- Analyst Decision
- BBIO Strong Buy
- FICO Buy
- Analyst Count
- BBIO 15
- FICO 12
- Target Price
- BBIO $61.20
- FICO $2,228.00
- AVG Volume (30 Days)
- BBIO 3.4M
- FICO 341.1K
- Earning Date
- BBIO 07-31-2025
- FICO 07-30-2025
- Dividend Yield
- BBIO N/A
- FICO N/A
- EPS Growth
- BBIO N/A
- FICO 21.78
- EPS
- BBIO N/A
- FICO 23.21
- Revenue
- BBIO $127,415,000.00
- FICO $1,840,361,000.00
- Revenue This Year
- BBIO $107.34
- FICO $17.67
- Revenue Next Year
- BBIO $49.48
- FICO $15.78
- P/E Ratio
- BBIO N/A
- FICO $64.84
- Revenue Growth
- BBIO N/A
- FICO 14.71
- 52 Week Low
- BBIO $21.72
- FICO $1,484.29
- 52 Week High
- BBIO $48.68
- FICO $2,402.52
- Technical
- Relative Strength Index (RSI)
- BBIO 69.90
- FICO 27.12
- Support Level
- BBIO $45.73
- FICO $1,520.00
- Resistance Level
- BBIO $48.68
- FICO $1,905.33
- Average True Range (ATR)
- BBIO 1.46
- FICO 90.85
- MACD
- BBIO 0.15
- FICO -33.97
- Stochastic Oscillator
- BBIO 75.06
- FICO 6.10
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.